Search results
Showing results for
Twelve outstanding articles have been shortlisted for this year’s Max Perutz Science Writing Award, the MRC’s annual writing competition. The shortlist includes our DPhil student Magda Mareckova (pictured).
Kazem Rahimi
FRCP, DM, MSc, FESC Kazem Rahimi - Professor of Cardiovascular Medicine and Population Health
Dagan Wells
BSc (hons), PhD, FRCPath, FRSB, FIBMS, FRCOG Dagan Wells - Professor of Reproductive Genetics
Brittany Vining
BSc, CertScTech, GradDipReproSci, PhD Brittany Vining - Postdoctoral Research Assistant in Cell Reprogramming and Culture
Rebecca Dragovic
BSc (Hons) DPhil (oxon) Rebecca Dragovic - Director of the MSc in Clinical Embryology
Michelle Potter
BSc (Hons), MSc (Hons), DPhil (Oxon) Michelle Potter - Research Grants, Contracts & Facilitation Manager
Aris Papageorghiou
MBChB, MRCOG Aris Papageorghiou - Professor of Fetal Medicine and Director of Research of the Oxford Maternal and Perinatal Health Institute (OMPHI).
Katy Vincent
DPhil BSc MBBS MRCOG Katy Vincent - Professor of Gynaecological Pain and Honorary Consultant Gynaecologist
Latest news
Oxford researchers develop wearable ultrasound patch for continuous pregnancy monitoring
26 May 2026
New technology could help identify fetal complications earlier in high-risk pregnancies. Researchers at the University of Oxford and collaborators have helped develop a wearable ultrasound patch capable of continuously monitoring fetal wellbeing during pregnancy, offering a potential new approach to identifying complications earlier in high-risk pregnancies.
Targeted Removal of sFlt-1 in Very Preterm Preeclampsia: A Promising First-in-Human Pilot Study
15 May 2026
A first-in-human pilot study, published in Nature Medicine, suggests that selectively removing a placenta-derived protein called soluble Fms-like tyrosine kinase 1 (sFlt-1) from the blood may be a safe and feasible way to help manage very preterm preeclampsia.
Oxford to lead Europe's largest miscarriage research centre in partnership with Tommy's
13 May 2026
The Nuffield Department of Women's & Reproductive Health is proud to announce that it is now leading Tommy's National Centre for Miscarriage Research, alongside existing partners: the University of Birmingham, the University of Warwick, and Imperial College London.
Ovarian Cancer Awareness Day 2026 highlights the need for earlier detection and better outcomes
8 May 2026
Today, on World Ovarian Cancer Day, we recognise the impact ovarian cancer has on women and families worldwide, and the urgent need for earlier diagnosis, improved treatment, and better survival outcomes. The day also highlights the importance of continued research to improve understanding of ovarian cancer biology, diagnosis, treatment, and patient outcomes. High-grade serous ovarian cancer is the most common subtype of ovarian cancer, with many patients diagnosed at an advanced stage. Survival outcomes remain closely linked to the stage at which the disease is diagnosed.